Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

FDA approves Fetroja for the treatment of HABP and VABP

Sep. 29, 2020

FDA approves Nucala for hypereosinophilic syndrome

Sep. 28, 2020

Japan first to approve Ecclock for primary axillary hyperhidrosis

Sep. 28, 2020

Enhertu approved in Japan for HER2-positive metastatic gastric cancer

Sep. 28, 2020

Japanese approval for Jyseleca in rheumatoid arthritis

Sep. 25, 2020

FDA approves Trelegy Ellipta for asthma

Sep. 14, 2020

FDA approves Detectnet

Sep. 9, 2020

FDA grants accelerated approval to Gavreto for metastatic RET fusion-positive NSCLC

Sep. 7, 2020

FDA approves Sogroya for adult growth hormone deficiency

Sep. 2, 2020

FDA approves Winlevi for acne

Aug. 27, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...